Discover
QSI
Quantum-Si incorporated
0.92
2 x 0.66
7 x 0.92
bid
ask
+
0.04
4.42%
5 @ 06:17 AM
0.94 +0.02 (1.69%)
| Ytd | -15.99% | |
| 1y | -51.36% |
0.88
day range
0.96
0.69
52 week range
3.10
| Open | 0.88 | Prev Close | 0.89 | Low | 0.88 | High | 0.96 | Mkt Cap | 201.23M |
| Vol | 5.49M | Avg Vol | 6.25M | EPS | -0.50 | P/E | N/A | Forward P/E | -1.66 |
| Beta | 2.93 | Short Ratio | 0.53 | Inst. Own | 36.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 0.98 | 200-d Avg | 1.22 | 1yr Est | 3.25 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.21 | -0.18 | 0.03 | 14.29% |
| 2024-08-07 | 2024-06 | -0.21 | -0.16 | 0.05 | 23.81% |
| 2024-08-07 | 2024-06 | -0.21 | N/A | N/A | N/A |
| 2024-05-09 | 2024-03 | -0.23 | -0.14 | 0.09 | 39.13% |
| 2024-05-09 | 2024-03 | -0.23 | N/A | N/A | N/A |
| 2024-02-29 | 2023-12 | -0.16 | -0.16 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-11-13 | Canaccord Genuity | Upgrade | Hold | Hold |
| 2024-11-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-03-01 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-12-08 | HC Wainwright & Co. | Upgrade | Buy |
Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-09-16 | BENNETT TODD C | Officer | 510.15K | Stock Award(Grant) |
| 2024-03-21 | DOWDY PAULA | Director | 159.22K | Stock Award(Grant) |
| 2024-08-08 | HAWKINS JEFFREY ALAN | Chief Executive Officer | 1.00M | Purchase |
| 2023-09-24 | JAFRI AMIR | Director | 115.94K | Stock Award(Grant) |
| 2024-06-23 | JOHNSTON GRACE | Officer | 295.94K | Sale |
| 2023-05-21 | KENNY JOHN P | Director | 114.29K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | ARK Investment Management, LLC | 11.84M | 15.51M | 9.65% |
| 2024-09-29 | Sumitomo Mitsui Trust Holdings, Inc. | 7.55M | 9.89M | 6.15% |
| 2024-09-29 | Nikko Asset Management Americas, Inc. | 7.53M | 9.86M | 6.13% |
| 2024-09-29 | Blackrock Inc. | 6.90M | 9.04M | 5.62% |
| 2024-09-29 | Vanguard Group Inc | 5.04M | 6.60M | 4.10% |
| 2024-09-29 | Geode Capital Management, LLC | 2.32M | 3.04M | 1.89% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | ARK ETF Tr-ARK Genomic Revolution ETF | 11.50M | 15.06M | 9.36% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 3.02M | 3.95M | 2.46% |
| 2024-10-30 | iShares Russell 2000 ETF | 2.44M | 3.20M | 1.99% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 1.28M | 1.67M | 1.04% |
| 2024-08-30 | Fidelity Small Cap Index Fund | 1.03M | 1.35M | 0.84% |
| 2024-10-30 | iShares Russell 2000 Value ETF | 1.02M | 1.34M | 0.83% |